Familial gastric cancer - clinical management

Best Practice and Research: Clinical Gastroenterology

Volumn 20, Issue 4, 2006, Pages 735-743

  Fitzgerald, Rebecca C ^a   Caldas, Carlos ^b  

^a HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

diffuse gastric cancer; E cadherin; prophylactic gastrectomy; signet ring cell carcinoma; surveillance endoscopy

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; PACLITAXEL; UVOMORULIN;

ARTICLE; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CASE MANAGEMENT; FAMILIAL CANCER; GASTRECTOMY; GASTROSCOPY; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GERM LINE; HELICOBACTER PYLORI; HUMAN; NONHUMAN; RELATIVE; RISK FACTOR; STOMACH CANCER; SYMPTOMATOLOGY;

ENDOSCOPY, GASTROINTESTINAL; GASTRECTOMY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 33748773681     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2006.03.013     Document Type: Article

References (42)

1. Gayther S.A., Gorringe K.L., Ramus S.J., et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58 (1998) 4086-4089
2. Oliveira C, Bordin MC, Grehan N et al. Screening E-Cadherin in gastric cancer families reveals germ-line mutations only in hereditary diffuse gastric cancer kindred. Human Mutat [in press].
3. Park J.G., Yang H.K., Kim W.H., et al. Report on the first meeting of the International Collaborative Group on Hereditary Gastric Cancer. J Natl Cancer Inst 92 (2000) 1781-1782
4. Guilford P.J., Hopkins J.B., Grady W.M., et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 14 (1999) 249-255
5. Richards F.M., McKee S.A., Rajpar M.H., et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 8 (1999) 607-610
6. Pharoah P.D., Guilford P., and Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121 (2001) 1348-1353
7. Suriano G., Yew S., Ferreira P., et al. Characterization of a recurrent germ line mutation of the e-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 11 (2005) 5401-5409
8. Caldas C., Carneiro F., Lynch H.T., et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 36 (1999) 873-880
9. Ramos-De la Medina A., Salgado-Nesme N., Torres-Villalobos G., et al. Clinicopathologic characteristics of gastric cancer in a young patient population. J Gastrointest Surg 8 (2004) 240-244
10. Guilford P., Hopkins J., Harraway J., et al. E-cadherin germline mutations in familial gastric cancer. Nature 392 (1998) 402-405
11. Keller G., Vogelsang H., Becker I., et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 155 (1999) 337-342
12. (IGCLC). I.G.C.L.C., First Worskshop of the International Gastric Cancer Linkage Consortium (IGCLC) (1999), University of Cambridge, Cambridge
13. Renkonen-Sinisalo L., Sipponen P., Aarnio M., et al. No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer. Scand J Gastroenterol 37 (2002) 574-577
14. Charlton A., Blair V., Shaw D., et al. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 53 (2004) 814-820
15. Carneiro F., Huntsman D.G., Smyrk T.C., et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203 (2004) 681-687
16. Shaw D., Blair V., Framp A., et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?. Gut 54 (2005) 461-468
17. Rembacken B., Fujii T., and Kondo H. The recognition and endoscopic treatment of early gastric and colonic cancer. Best Pract Res Clin Gastroenterol 15 (2001) 317-336
18. van Kouwen M.C., Drenth J.P., Oyen W.J., et al. [18F]Fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier. Clin Cancer Res 10 (2004) 6456-6459
19. Machado J.C., Figueiredo C., Canedo P., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125 (2003) 364-371
20. Chen A., Li C.N., Hsu P.I., et al. Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer. Aliment Pharmacol Ther 20 (2004) 203-211
21. Eurogast S.G. An international association between Helicobacter pylori infection and gastric cancer. Lancet 341 (1993) 1359-1362
22. Kikuchi S., Wada O., Nakajima T., et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer 75 (1995) 2789-2793
23. Campbell S., Fraser A., Holliss B., et al. Evidence for ethnic tropism of Helicobacter pylori. Infect Immun 65 (1997) 3708-3712
24. McColl K.E., and El-Omar E. E-cadherin germline mutations and risk of gastric cancer. Gastroenterology 123 (2002) 1406 author reply 1406-1407
25. Grady W.M., Willis J., Guilford P.J., et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26 (2000) 16-17
26. Graff J.R., Herman J.G., Lapidus R.G., et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55 (1995) 5195-5199
27. Graff J.R., Greenberg V.E., Herman J.G., et al. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res 58 (1998) 2063-2066
28. Yoshiura K., Kanai Y., Ochiai A., et al. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A 92 (1995) 7416-7419
29. Machado J.C., Oliveira C., Carvalho R., et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20 (2001) 1525-1528
30. Fang J., and Xiao S. Alteration of DNA methylation in gastrointestinal carcinogenesis. J Gastroenterol Hepatol 16 (2001) 960-968
31. Huntsman D.G., Carneiro F., Lewis F.R., et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 344 (2001) 1904-1909
32. Chun Y.S., Lindor N.M., Smyrk T.C., et al. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?. Cancer 92 (2001) 181-187
33. Lewis F.R., Mellinger J.D., Hayashi A., et al. Prophylactic total gastrectomy for familial gastric cancer. Surgery 130 (2001) 612-617 discussion 617-619
34. Miholic J., Meyer H.J., Kotzerke J., et al. Emptying of the gastric substitute after total gastrectomy. Jejunal interposition versus Roux-y esophagojejunostomy. Ann Surg 210 (1989) 165-172
35. Miholic J., Meyer H.J., Muller M.J., et al. Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms, and body composition. Surgery 108 (1990) 488-494
36. Cuschieri A. Jejunal pouch reconstruction after total gastrectomy for cancer: experience in 29 patients. Br J Surg 77 (1990) 421-424
37. Fitzgerald R.C., and Caldas C. E-cadherin mutations and hereditary gastric cancer: prevention by resection?. Dig Dis 20 (2002) 23-31
38. Allum W.H., S.M., G., A., W., D., and C.-J. Guidelines for the management of oeosphageal and gatsric cancer. Gut 50 (2002) 1-23
39. Ferreira P., Oliveira M.J., Beraldi E., et al. Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro. Exp Cell Res 310 (2005) 99-104
40. Berx G., Cleton-Jansen A.M., Nollet F., et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. Embo J 14 (1995) 6107-6115
41. Salahshor S., Hou H., Diep C.B., et al. A germline E-cadherin mutation in a family with gastric and colon cancer. Int J Mol Med 8 (2001) 439-443
42. Blazeby J.M., Metcalfe C., Nicklin J., et al. Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia. Br J Surg (2005) Epub ahead of print